WST

West Pharmaceutical Services Stock Analysis

AI Rating

Neutral
  • Quality9/10
  • Growth↓ 3/10
  • Value↓ 1/10
West Pharmaceutical Services sales and earnings growth
WST Growth
Neutral
  • Revenue Y/Y↑ 11.23%
  • EPS Y/Y↑ 17.13%
  • FCF Y/Y↑ 49.23%
West Pharmaceutical Services gross and profit margin trends
WST Profitability
Great
  • Gross margin ↑ 36.30%
  • EPS margin↑ 16.80%
  • ROIC 5Y↑ 23.94%
West Pharmaceutical Services recent dividend growth
WST Dividends
  • Dividend yield 0.27%
  • Growth 3Y↑ 5.00%
  • Payout ratio↑ 11%
West Pharmaceutical Services net debt vs free cash flow
WST Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 343.5

West Pharmaceutical Services stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Medical Instruments & Supplies stocks